Deerfield.Com (Singulargenomics.Com)

Singular Genomics https://www.singulargenomics.com/ The company, known for its next-generation sequencing technologies such as the G4® Sequencing Platform and the upcoming G4XTM Spatial Sequencer, is now focused on further innovation in genomic and spatial multiomics research. Singular Genomics Systems, Inc. is a life science technology company founded in 2016 that develops next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians in advancing science and medicine. The company's mission centers on leveraging its proprietary Sequencing Engine platform, which underpins its core product tenets of accuracy, speed, flexibility, and scale. Its commercially available G4 Sequencing Platform is a benchtop genomic sequencer designed for fast and accurate results, while the G4X Spatial Sequencer, an upgrade to the G4 platform, enables high-throughput in situ direct sequencing of RNA, targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues. The company is also developing the PX Integrated Solution, a multiomics platform that combines single-cell analysis, spatial analysis, genomics, and proteomics in one instrument. As of February 21, 2025, Singular Genomics was taken private following the closing of an acquisition by Deerfield Management. The company is headquartered in San Diego, California, with additional operations in La Jolla. Target CEO: Drew Spaventa https://www.linkedin.com/in/drew-spaventa-98087213/ Josh Stahl https://www.linkedin.com/in/joshua-stahl-77238627/ Target Owner: James E. Flynn https://www.linkedin.com/in/james-flynn-99304a72/ Deerfield Management Company, L.P. Singular Genomics is currently owned by Deerfield Management Company, L.P., following the completion of its acquisition on February 21, 2025. The transaction involved an affili

================================================================================================ deerfield.com Deerfield Management ("Deerfield") is an American investment firm headquartered in New York City. It is focused on making public and private investments in the healthcare and biotechnology industries. Deerfield is considered to be one of the largest dedicated healthcare investment firms in the world. ================================================================================================ We hacked and compromised one of the many laboratories belonging to Deerfield: ================================================================================================ www.singulargenomics.com A Singular Focus on Advancing Science and Medicine Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. Our commitment is to serve the scientific community through continuous and thoughful genomic innovation that's driven by real-world feedback and solution-oriented development. ================================================================================================ We downloaded about 20 TERABYTES of data from servers and Amazon storage. Including experiments, software sources, AI data, as well as research for the company's clients - fox chase, GeneDX, Juno, lexogen, HARVARD, siemens, and many others. Soon, anyone who wants and understands the issue will have the opportunity to study in detail the activities, research and experiments of this company. And to see who and why they are conducting their experiments in the field of gene engineering. Maybe it will become clearer why Deerfield is buying up pharmaceutical laboratories and what they want to achieve in the end. What do gene laboratories and government universities have in common? Everyone will soon be able to d